Home > Research > Projects > Phase IIb, Randomised, Double-blinded, Placebo ...
View graph of relations

Phase IIb, Randomised, Double-blinded, Placebo Controlled, Multicentre Trial of Infliximab with Transcriptomic Biomarker and Mechanism Evaluation – RAPID-1

Project: Research

StatusActive
Effective start/end date1/01/1830/04/21

Funding

  • NIHR: £9,280.00